Literature DB >> 31806672

Bedside clinical assessment predicts recurrence after hospitalization due to viral lower respiratory tract infection in young children.

Maria Arroyo1, Kyle P Salka2, Geovanny F Perez3, Carlos E Rodriguez-Martinez4,5, Jose A Castro-Rodriguez6, Gustavo Nino7.   

Abstract

Infants requiring hospitalization due to a viral lower respiratory tract infection (LRTI) have a high risk of developing recurrent respiratory illnesses in early life and asthma beyond childhood. Notably, all validated clinical scales for viral LRTI have focused on predicting acute severity instead of recurrence. We present a novel clinical approach combining individual risk factors with bedside clinical parameters to predict recurrence after viral LRTI hospitalization in young children. A retrospective longitudinal cohort of young children (≤3 years) designed to define clinical predictive factors of recurrent respiratory illnesses within 12 months after hospitalization due to PCR-confirmed viral LRTI. Data collection was through electronic medical record. We included 138 children hospitalized with viral LRTI. Using automatic stepwise logistic model selection, we found that the strongest predictors of recurrence in infants hospitalized for the first time were severe prematurity (≤32 weeks' gestational age, OR=5.19; 95% CI 1.76 to 15.32; p=0.002) and a clinical score that weighted hypoxemia, subcostal retractions and wheezing (OR=3.33; 95% CI 1.59 to 6.98; p<0.001). After the first hospitalization, the strongest predictors of subsequent episodes were wheezing (OR=5.62; 95% CI 1.03 to 30.62; p=0.04) and family history of asthma (OR=5.39; 95% CI 1.04 to 27.96; p=0.04). We found that integrating individual risk factors (eg, prematurity or family history of asthma) with bedside clinical assessment (eg, wheezing, subcostal retractions or hypoxemia) can predict the risk of recurrence after viral LRTI hospitalization in infants. This strategy may enable clinically oriented subsetting of infants with viral LRTI based on individual predictors for recurrent respiratory illnesses during early life. © American Federation for Medical Research 2020. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  asthma; clinical research; infant, newborn, diseases; respiratory tract diseases

Mesh:

Year:  2019        PMID: 31806672      PMCID: PMC7336335          DOI: 10.1136/jim-2019-001024

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  23 in total

1.  A clinical index to define risk of asthma in young children with recurrent wheezing.

Authors:  J A Castro-Rodríguez; C J Holberg; A L Wright; F D Martinez
Journal:  Am J Respir Crit Care Med       Date:  2000-10       Impact factor: 21.405

2.  Prospective multicenter study of viral etiology and hospital length of stay in children with severe bronchiolitis.

Authors:  Jonathan M Mansbach; Pedro A Piedra; Stephen J Teach; Ashley F Sullivan; Tate Forgey; Sunday Clark; Janice A Espinola; Carlos A Camargo
Journal:  Arch Pediatr Adolesc Med       Date:  2012-08

3.  Clinical practice guideline: the diagnosis, management, and prevention of bronchiolitis.

Authors:  Shawn L Ralston; Allan S Lieberthal; H Cody Meissner; Brian K Alverson; Jill E Baley; Anne M Gadomski; David W Johnson; Michael J Light; Nizar F Maraqa; Eneida A Mendonca; Kieran J Phelan; Joseph J Zorc; Danette Stanko-Lopp; Mark A Brown; Ian Nathanson; Elizabeth Rosenblum; Stephen Sayles; Sinsi Hernandez-Cancio
Journal:  Pediatrics       Date:  2014-11       Impact factor: 7.124

Review 4.  Understanding airway disease in infants.

Authors:  J D Finder
Journal:  Curr Probl Pediatr       Date:  1999-03

5.  Community-acquired pneumonia requiring hospitalization among U.S. children.

Authors:  Seema Jain; Derek J Williams; Sandra R Arnold; Krow Ampofo; Anna M Bramley; Carrie Reed; Chris Stockmann; Evan J Anderson; Carlos G Grijalva; Wesley H Self; Yuwei Zhu; Anami Patel; Weston Hymas; James D Chappell; Robert A Kaufman; J Herman Kan; David Dansie; Noel Lenny; David R Hillyard; Lia M Haynes; Min Levine; Stephen Lindstrom; Jonas M Winchell; Jacqueline M Katz; Dean Erdman; Eileen Schneider; Lauri A Hicks; Richard G Wunderink; Kathryn M Edwards; Andrew T Pavia; Jonathan A McCullers; Lyn Finelli
Journal:  N Engl J Med       Date:  2015-02-26       Impact factor: 91.245

6.  Multicenter study of viral etiology and relapse in hospitalized children with bronchiolitis.

Authors:  Kohei Hasegawa; Jonathan M Mansbach; Stephen J Teach; Erin S Fisher; Daniel Hershey; Joyce Y Koh; Sunday Clark; Pedro A Piedra; Ashley F Sullivan; Carlos A Camargo
Journal:  Pediatr Infect Dis J       Date:  2014-08       Impact factor: 2.129

7.  Predictors of severe disease in a hospitalized population of children with acute viral lower respiratory tract infections.

Authors:  Angela M Pedraza-Bernal; Carlos E Rodriguez-Martinez; Ranniery Acuña-Cordero
Journal:  J Med Virol       Date:  2015-10-05       Impact factor: 2.327

8.  Recent trends in severe respiratory syncytial virus (RSV) among US infants, 1997 to 2000.

Authors:  Shelah Leader; Kimmie Kohlhase
Journal:  J Pediatr       Date:  2003-11       Impact factor: 4.406

9.  Age-Related Effect of Viral-Induced Wheezing in Severe Prematurity.

Authors:  Geovanny F Perez; Amisha Jain; Bassem Kurdi; Rosemary Megalaa; Krishna Pancham; Shehlanoor Huseni; Natalia Isaza; Carlos E Rodriguez-Martinez; Mary C Rose; Dinesh Pillai; Gustavo Nino
Journal:  Children (Basel)       Date:  2016-10-20

10.  Viral lower respiratory tract infections and preterm infants' healthcare utilisation.

Authors:  Simon B Drysdale; Mireia Alcazar-Paris; Theresa Wilson; Melvyn Smith; Mark Zuckerman; Janet L Peacock; Sebastian L Johnston; Anne Greenough
Journal:  Eur J Pediatr       Date:  2014-07-19       Impact factor: 3.183

View more
  1 in total

Review 1.  For which infants with viral bronchiolitis could it be deemed appropriate to use albuterol, at least on a therapeutic trial basis?

Authors:  Carlos E Rodríguez-Martínez; Gustavo Nino; Jose A Castro-Rodriguez; Ranniery Acuña-Cordero; Monica P Sossa-Briceño; Fabio Midulla
Journal:  Allergol Immunopathol (Madr)       Date:  2021-01-02       Impact factor: 1.667

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.